Abiopharma

🔍 Simanovsky Michael (Executive)

Company: SONIDA SENIOR LIVING, INC. (SNDA)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 115,000 shares of Common Stock at $40.7115 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 254,447.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 15,086 shares of Common Stock at $40.9373 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 239,361.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 15,000 shares of Common Stock at $39.0 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 224,361.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 6,857,823.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 807,115.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 1,032,216.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 648,942.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 3,199,998.00 | Footnotes: F9
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 224,829.00 | Footnotes: F9
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 652,356.00 | Footnotes: F9

Footnotes:

• F1: Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $40.50 to $41.00. The Reporting Persons (as defined below) hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F2: The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.
• F3: Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $40.50 to $41.40. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F4: Conversant GP Holdings LLC ("Conversant GP") is the general partner of each of Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"), Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B"), Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D"), and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F"). Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D, and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky and Conversant Capital may be deemed a beneficial owner of these securities, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein.
• F5: Securities are held by Investor A.
• F6: Securities are held by Investor B.
• F7: Securities are held by Investor D.
• F8: Securities are held by Investor F.
• F9: Conversant Private GP LLC ("Conversant Private GP") is the general partner of CPIF K Co-Invest SPT A, L.P., a Cayman Islands exempted limited partnership ("CPIF K"), Conversant PIF Aggregator A LP, a Delaware limited partnership ("Aggregator A") and CPIF SAF. Conversant Capital is the investment manager to each of Aggregator A, CPIF K and CPIF SAF. Mr. Simanovsky is the managing member of Conversant Capital and Conversant Private GP. By virtue of these relationships, each of Mr. Simanovsky and Conversant Capital may be deemed a beneficial owner of these securities, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein.
• F10: Securities are held by Aggregator A.
• F11: Securities are held by CPIF K.
• F12: Securities are held by CPIF SAF.
• REMARKS: Michael Simanovsky, Conversant Capital's Managing Partner, and Robert T. Grove, a Principal of Conversant Capital, serve as members of the Issuer's board of directors. On the basis of the relationship between Messrs. Simanovsky and Grove and the Reporting Persons, each of the Reporting Persons may be considered a director of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.